Skip to main content
Signal8

INNOCAN PHARMA Corp (INNPF)

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

InnoCan Pharma Corporation logo

InnoCan Pharma Corporation

OTC:INNPFHealthcare
Mkt Cap-
EV-
Float3.58M
O/S-
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 3.58M · FMP free float

15
Oct 15 (33d)prev 15– 0.0%
1.00
Oct 15 (33d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow INNPF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
100.0%
Oct 26 (22d)prev 91.5%▲ 8.5 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

Outside our fails-to-deliver ingest scope, so not measured for this ticker.
Price, short interest & fails to deliver
Short interest · today's share basis22 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 15, 202615 sh
Sep 30, 202615 sh
Sep 15, 20261.6K sh
Aug 31, 202615 sh
Aug 14, 202615 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Oct 26
Latest sessions
DateReported short
Oct 26, 2026100.0%
Oct 1, 202691.5%
Aug 4, 202650.0%
Jul 31, 2026100.0%
3-session median 91.5%mean 80.5%range 50.0–100.0%

130 calendar days requested; 4 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for INNPF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 15 INNPF shares were sold short (<0.01% of a 3.58M-share float, 1.00 days to cover).